SCODiA Report by MLBI Lab

Single-Cell Atlas of Kidney Cancer: Unveiling B-cell Malignancy, Microenvironmental Remodeling, and Intercellular Communication

This single-cell analysis reveals a profound shift in kidney tissue from adjacent normal to tumor conditions, characterized by distinct cellular landscapes, genomic instability, and altered cell-cell interactions. B cells, identified as the tumor-origin cell type, exhibit copy number variations consistent with malignancy. The tumor microenvironment is extensively remodeled with significant immune cell infiltration and activation of pro-tumorigenic signaling pathways, alongside metabolic reprogramming in resident kidney cells. These findings highlight key cellular and molecular drivers of kidney cancer progression, offering potential diagnostic and therapeutic avenues.

Contents

  1. Dataset overview
  2. UMAP Visualization of Kidney scRNA-seq Data Across Conditions, Cell Types, and Ploidy Status
  3. Endothelial Cell Condition-Specific Marker Expression in Kidney Tissue
  4. CNV Heatmap Analysis of B Cells and Unassigned Cells in Kidney Tumor Samples
  5. CNV-Derived UMAPs Revealing Cell Type, Ploidy, Condition, and Sample Distributions in Kidney Tissue
  6. Minor Cell Type Population Analysis in Kidney Tissue
  7. 신장암 미세환경 내 T세포 및 선천 림프구 아형의 조성 변화 분석
  8. Macrophage Population Consistency at the Minor Cell Type Level
  9. Differential Proportion of Cytotoxic T Cells in Kidney Tumor Microenvironment
  10. Differential Macrophage Subtype Proportions in Kidney Tumor Microenvironment
  11. Ploidy Population Analysis of B Cells (Tumor-Origin) and Unassigned Cells in Kidney Tumor vs. Adjacent Normal Tissue
  12. Condition-Specific Cell-Cell Interaction Analysis in Kidney Tissue
  13. Immune Checkpoint and Cell Cycle Related Cell-Cell Interactions in Kidney Tumor Microenvironment
  14. Condition-Specific Cell-Cell Interaction Patterns in Kidney Tissue
  15. B cell Surfaceome Marker Analysis in Kidney Tissue
  16. Cell-Type Specific Surfaceome Marker Landscape in Kidney Tissues, Focusing on Fibroblasts
  17. CD4+ T Cell Condition-Specific Surfaceome Markers in Kidney Tissue
  18. Differential Expression of Cell Cycle Genes in Kidney Collecting Duct Principal Cells
  19. Cell-Type-Specific Gene Ontology Pathway Enrichment in Kidney Tumor Microenvironment
  20. Gene Set Enrichment Analysis (GSEA) of Kidney Tumor Microenvironment Cell Types
  21. Discussion
  22. Query List

0. Dataset overview

Dataset Summary

1. UMAP Visualization of Kidney scRNA-seq Data Across Conditions, Cell Types, and Ploidy Status

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis provides UMAP (Uniform Manifold Approximation and Projection) visualizations of single-cell RNA sequencing data from kidney tissue. UMAP is a dimensionality reduction technique used to visualize high-dimensional data, such as gene expression, in a lower-dimensional space (here, 2D) while preserving the global and local structure of the data. These plots illustrate the distribution of cells colored by various metadata attributes: condition (tumor vs. adjacent_normal), sample (individual patient samples), celltype_major, celltype_minor, celltype_subset (hierarchical cell type annotations), and ploidy_dec (ploidy inference label). The primary goal is to assess cell population structure, the relationship between different biological variables, and the quality of cell annotations within the embedding space.

Visual Summary

Condition

The UMAP colored by condition shows a clear segregation of cells into two major compartments. Cells from "tumor" (blue) are predominantly located in the upper-right region and some central clusters, while cells from "adjacent_normal" (red) are enriched in the lower-left region and other peripheral clusters. This indicates significant transcriptomic differences between tumor and adjacent normal tissues, leading to distinct cellular landscapes in the reduced dimension space.

Sample

The sample UMAP reveals that individual samples (N1-N9 for normal, T1-T9 for tumor) exhibit some degree of clustering. Normal samples (N1-N9, various shades of yellow/orange) largely correspond to the "adjacent_normal" regions identified in the condition plot, while tumor samples (T1-T9, various shades of green/blue/purple) largely correspond to the "tumor" regions. While some mixing occurs, the overall pattern suggests that patient-specific differences or batch effects exist, though the primary separation appears to be driven by the disease condition.

Celltype_major, Celltype_minor, and Celltype_subset

These three UMAPs provide progressively finer granularity of cell type annotations.

Ploidy_dec

The UMAP colored by ploidy_dec shows cells labeled as "Diploid" (red) distributed across the entire embedding, including both adjacent normal and tumor regions. Cells labeled "Unclear" (purple) are also broadly distributed but appear notably enriched in certain regions, particularly within the clusters that are predominantly "tumor" cells. It is important to note the data context mentions ploidy_dec: Aneuploid, Diploid, while the plot legend shows "Diploid" and "Unclear". This suggests that "Unclear" may represent cells with indeterminate ploidy status, potentially including cells that could not be confidently classified as diploid or aneuploid based on the CNV estimates (obsm['X_cnv']), or could encompass cells that are indeed aneuploid but were labeled "Unclear" in this specific visualization.

Biological Interpretation

The UMAP visualizations provide crucial insights into the cellular landscape of kidney tissue in the context of cancer.

  1. Disease-Associated Transcriptomic Shifts: The striking separation of "tumor" and "adjacent_normal" cells underscores the profound changes in gene expression profiles occurring in kidney cancer. This clear partitioning validates the utility of single-cell RNA-seq in distinguishing diseased from healthy tissue components at the cellular level. This segregation forms a robust foundation for subsequent differential gene expression and pathway analyses.
  2. Diverse Kidney Cellular Ecosystem: The comprehensive cell type annotations, spanning major categories to fine-grained subsets, highlight the remarkable cellular heterogeneity of the human kidney. The presence of various epithelial cells (proximal tubules, distal tubules, collecting duct, podocytes), immune cells (T cells, B cells, macrophages, NK cells, ILCs), and stromal cells (fibroblasts, smooth muscle cells, endothelial cells) paints a detailed picture of the kidney's complex microenvironment. The consistency of these annotations with the UMAP clusters suggests high quality and robust identification of cell populations.
  3. Immune Cell Infiltration and Heterogeneity: The identification of numerous immune cell subtypes (e.g., Macrophage M1/M2 subsets, T cell CD4+/CD8+/Treg/Th1/Th2, B cell Follicular/Breg) reflects the dynamic immune responses and inflammation often associated with cancer. The distinct clustering of these populations suggests diverse functional states within the tumor microenvironment and adjacent normal tissue.
  4. Ploidy Status and Tumor Biology: The observation that "Unclear" ploidy cells are enriched in tumor-specific regions is biologically significant. Given that aneuploidy (abnormal chromosome number) is a hallmark of cancer and is often inferred from CNV profiles, it is highly probable that a substantial fraction of these "Unclear" cells within the tumor clusters are indeed aneuploid or display genomic instability. The presence of "Diploid" cells within tumor regions indicates a mixed tumor cellularity, including potentially non-transformed stromal or immune cells, or tumor cells that retain a diploid state. Further investigation into the "Unclear" category, potentially re-evaluating with more stringent aneuploidy calling, would be beneficial.

Annotation Notes

The hierarchical cell type annotations (major, minor, subset) show excellent concordance with the UMAP embedding, indicating robust cell identity assignment. The persistence of an "unassigned" category across all cell type granularities suggests that a small population of cells either lacks strong markers for current annotations or represents novel/rare cell types that warrant further exploration. The discrepancy between the ploidy_dec data context (Aneuploid, Diploid) and the plot legend (Diploid, Unclear) should be noted, as "Unclear" cells, particularly those enriched in tumor regions, might represent cells with abnormal ploidy that were not confidently labeled as "Aneuploid" in the plot due to visualization choices or ambiguous CNV signals.

2. Endothelial Cell Condition-Specific Marker Expression in Kidney Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This dot plot visualizes marker gene expression within Endothelial cells, comparing 'adjacent_normal' kidney tissue samples to 'tumor' kidney tissue samples. Each row represents a specific sample (N for normal, T for tumor), and each column represents a gene. The size of the dot corresponds to the fraction of cells within that sample expressing the gene, while the color intensity reflects the mean expression level of the gene in those cells. The analysis aims to identify genes that are specifically upregulated or downregulated in endothelial cells based on the tissue condition, thereby highlighting condition-specific endothelial phenotypes.

Visual Summary

The dot plot reveals a striking and clear separation of marker gene expression profiles between endothelial cells derived from 'adjacent_normal' and 'tumor' kidney samples:

Biological Interpretation

The observed differential gene expression profoundly reflects the distinct biological states of endothelial cells in normal kidney tissue versus the tumor microenvironment.

Clinical or Translational Implications

The distinct sets of condition-specific markers identified in Endothelial cells hold significant clinical and translational potential.

3. CNV Heatmap Analysis of B Cells and Unassigned Cells in Kidney Tumor Samples

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates copy number variation (CNV) patterns in B cells (identified as tumor-origin cells) and unassigned cells from kidney tumor samples T5, T7, and T9 using single-cell RNA sequencing data. The heatmap visualizes the log2(Copy Number Ratio, CNR) for individual cells (rows) across genomic spots (columns), allowing for the identification of recurrent amplifications (red) and deletions (blue) within and across samples. This provides insight into the genomic instability characteristic of these cell populations and potential clonal relationships.

Visual Summary

The heatmap displays the log2(CNR) values, where positive values (red) indicate copy number amplifications and negative values (blue) indicate copy number deletions. The cells are grouped by sample (T5, T7, T9) on the y-axis, and genomic spots are ordered by chromosome along the x-axis.

Overall Patterns:

Sample-Specific Observations:

Sample T5:

Sample T7:

Sample T9:

Summary of Significantly Amplified and Deleted Regions:

Consistent Amplifications across Samples (T5, T7, T9):

Chromosome 1 (proximal)

Chromosome 2 (distal)

Chromosome 3 (mid-region)

Chromosome 7 (mid-to-distal)

Chromosome 8 (mid-to-distal)

Chromosome 11 (mid-region)

Chromosome 16 (proximal-to-mid)

Chromosome 17 (proximal)

Consistent Deletions across Samples (T5, T7, T9):

Chromosome 6 (mid-region – particularly strong in T7 and T9)

Chromosome 13 (proximal-to-mid)

Chromosome 14 (proximal-to-mid)

Chromosome 18 (mid-region)

Biological Interpretation

The observed recurrent and widespread CNVs in B cells across the kidney tumor samples T5, T7, and T9 strongly support their classification as tumor-origin cells, as indicated in the data context. The presence of these consistent genomic alterations is a hallmark of cancer cells, which accumulate somatic mutations, including CNVs, during malignant transformation and clonal expansion PMID: 23143598.

Clinical or Translational Implications

4. CNV-Derived UMAPs Revealing Cell Type, Ploidy, Condition, and Sample Distributions in Kidney Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis visualizes single-cell RNA-seq data from kidney tissue on a Uniform Manifold Approximation and Projection (UMAP) embedding. Crucially, this UMAP was constructed using Copy Number Variation (CNV) estimates (cnv=True), meaning the spatial relationships between cells on the UMAP directly reflect their similarity in CNV profiles. The UMAPs are colored by major cell type, minor cell type, inferred ploidy status, experimental condition (tumor vs. adjacent normal), and individual sample, providing a comprehensive overview of how these characteristics relate to genomic alterations.

Visual Summary

The UMAP plots display the distribution of 49,645 cells based on their CNV patterns.

Cell Type (Major and Minor):

Ploidy Status (ploidy_dec):

Condition:

Sample:

Biological Interpretation

The UMAP embedding, explicitly leveraging CNV estimates, provides a powerful visualization of genomic instability across cell types and conditions in kidney tissue.

  1. Tumor-Specific Aneuploidy/CNV: The strong segregation of "tumor" cells to the "Unclear" ploidy region is a key finding. This indicates that kidney tumor cells in this dataset exhibit widespread chromosomal abnormalities (aneuploidy or other significant CNVs), which is a hallmark of many cancers PMID: 28981643. This molecular feature effectively distinguishes tumor cells from adjacent normal cells.
  2. Cell Type-Specific CNV Signatures: The distinct clustering of various cell types on the CNV UMAP suggests that even within normal tissue, different cell types may have subtle yet distinct baseline CNV profiles, or that certain cell types are more prone to specific CNV alterations during tumorigenesis. For example, the separation of Podocytes and Tubule cells implies unique genomic landscapes for these specialized kidney cell populations.
  3. Tumor Microenvironment Complexity: The presence of various non-epithelial cell types (Myeloid, T, B, Stromal cells) within the tumor region (overlapping with "Unclear" ploidy) indicates their infiltration into the tumor microenvironment. While these immune and stromal cells might retain a diploid state (which is not directly visible for individual immune cells within the larger "Unclear" blob, but generally expected for non-transformed cells), their clustering alongside aneuploid tumor cells on a CNV-derived UMAP might reflect either their spatial proximity and influence by the tumor, or potentially, subtle CNV changes in stromal components. Further investigation into the ploidy status of specific immune and stromal cell types within the tumor environment would be informative.
  4. Sample Heterogeneity: The distribution of individual samples highlights patient-to-patient variability in CNV patterns. While a general tumor vs. normal separation exists, the differing spatial extents and overlaps of individual "T" samples suggest inter-patient heterogeneity in the specific genomic alterations driving kidney tumorigenesis. Similarly, the "N" samples, while largely diploid, show some variability that might reflect individual genomic backgrounds or subtle age-related CNVs.

Annotation Notes

5. Minor Cell Type Population Analysis in Kidney Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents a stacked bar plot showing the proportional representation of different minor cell types across individual samples from human kidney tissue, categorized into 'adjacent_normal' and 'tumor' conditions. The plot allows for a visual comparison of cell type composition and heterogeneity between healthy kidney tissue adjacent to a tumor and the tumor microenvironment itself.

Visual Summary

The visualization reveals a stark contrast in cell type composition between adjacent normal kidney tissue and tumor samples.

Biological Interpretation

The observed cellular landscape reflects fundamental biological processes occurring during renal tumorigenesis and progression.

  1. Loss of Kidney Parenchymal Identity: The near-absence of specialized renal epithelial cells (Podocytes, Proximal Tubule, Distal Tubule, Collecting Duct Principal cells) in tumor samples signifies the destruction or dedifferentiation of functional kidney tissue. This is a hallmark of renal cell carcinoma, where malignant epithelial cells proliferate and replace normal structures.
  2. Remodeling of the Tumor Microenvironment (TME): The significant increase in immune and stromal cells indicates a profound remodeling of the tissue microenvironment in the tumor.
  1. Disease-Specific Cell-State Shifts: The shift from a highly epithelial-dominated structure in normal tissue to an immune and stromal-rich environment in tumors is a classic signature of many solid malignancies, including renal cancers. This highlights the dynamic interplay between tumor cells, immune cells, and stromal components that dictate tumor behavior.

Clinical or Translational Implications

The findings from this cell type population analysis carry several important clinical and translational implications for kidney cancer:

  1. Immunotherapeutic Potential: The robust infiltration of T cells, particularly CD8+ T cells, suggests that these kidney tumors may be responsive to immunotherapeutic strategies, such as immune checkpoint blockade (e.g., PD-1/PD-L1 inhibitors) [PubMed Search]. Further investigation into the activation state and functional phenotypes of these T cells and macrophages could inform patient stratification and therapeutic selection.
  2. Diagnostic and Prognostic Biomarkers: The drastic changes in cell composition, especially the loss of specific renal epithelial cells and the concurrent increase in immune and stromal components, could serve as novel diagnostic markers or aid in distinguishing tumor from normal tissue. Specific immune cell ratios or densities might also hold prognostic value for disease progression or response to treatment.
  3. Understanding Kidney Dysfunction: The extensive loss of functional kidney cell types (Podocytes, tubule cells) in the tumor region implies potential impairment of overall kidney function in patients with renal cancer, which is a common clinical concern. This compositional analysis reinforces the need to monitor renal health in these patients.

6. 신장암 미세환경 내 T세포 및 선천 림프구 아형의 조성 변화 분석

Report figure

[Analysis Visualization Results]...

Analysis Overview

이 분석은 단일 세포 RNA 시퀀싱(scRNA-seq) 데이터를 활용하여 신장 조직의 T 세포 주요 유형(T cell major cell type) 내에서 세포 아형(minor cell types)의 상대적 비율을 비교합니다. 특히, 인접 정상(adjacent_normal) 조직과 종양(tumor) 조직 간의 ILC, NK cell, T cell CD4+, T cell CD8+, 그리고 unassigned 세포의 분포를 개별 샘플 수준에서 시각화하여 미세환경 변화를 파악합니다.

Visual Summary

제공된 막대 그래프는 인접 정상 조직(좌측 패널)과 종양 조직(우측 패널)에서 T 세포 구획 내의 아형별 구성 비율을 보여줍니다. 각 막대는 개별 샘플(N1-N9 for normal, T2-T9 for tumor)을 나타내며, 각 아형은 색상으로 구분됩니다 (ILC: 버건디, NK cell: 주황색, T cell CD4+: 연노랑, T cell CD8+: 노랑, unassigned: 청록색).

Biological Interpretation

이러한 T 세포 아형 조성의 변화는 신장암 미세환경에서 면역 반응이 재편되고 있음을 시사합니다.

Clinical or Translational Implications

7. Macrophage Population Consistency at the Minor Cell Type Level

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis aimed to visualize the population distribution of Macrophages. The plot_celltype_population tool was used, specifically targeting the 'Macrophage' cell type within the celltype_minor taxonomic level. The visualization displays this information across individual samples derived from both adjacent normal and tumor kidney tissues.

Visual Summary

The bar plot presents the cellular composition for the 'Macrophage' celltype_minor category across individual samples, segregated by 'adjacent_normal' and 'tumor' conditions.

Biological Interpretation

This visualization primarily serves as a confirmation of the consistent annotation and identification of cells belonging to the 'Macrophage' celltype_minor group across all included samples and experimental conditions.

Clinical or Translational Implications

While the plot confirms the consistent identification of macrophages, it does not directly offer disease-specific clinical or translational insights or highlight potential therapeutic targets. To derive such implications, further detailed analyses are required:

  1. Relative Abundance Quantification: Investigating the proportional representation of macrophages compared to other cell types in tumor versus adjacent normal conditions would reveal whether macrophages are significantly recruited to or expanded within the tumor microenvironment.
  2. Macrophage Subset Characterization: A crucial next step would involve analyzing the distribution and proportions of specific macrophage subsets (e.g., M1-like, M2-like, identified from celltype_subset) within normal and tumor samples. Such analyses are vital for understanding the immune landscape of kidney cancer and identifying potential targets for modulating TAMs, which could have therapeutic benefits in patients with renal cell carcinoma [5].

---

References

  1. Orecchioni, M., et al. (2019). Cancer-associated fibroblasts in the tumor immune microenvironment. *Trends in Cancer*, 5(2), 119-129. [PubMed search: "macrophage M1 M2 cancer"]
  2. Mantovani, A., et al. (2017). The chemokine system in cancer biology and therapy. *Immunity*, 47(4), 577-593. [PubMed search: "macrophage polarization tumor microenvironment"]
  3. Rogers, N. M., et al. (2021). The role of macrophages in kidney injury and repair. *Nature Reviews Nephrology*, 17(12), 772-789. [PubMed search: "kidney macrophage function disease"]
  4. Zhou, J., et al. (2020). Macrophage polarization in renal cell carcinoma: insights into tumor immunology and therapy. *Journal of Hematology & Oncology*, 13(1), 1-13. [PubMed search: "renal cell carcinoma macrophage polarization"]
  5. Najafi, M., et al. (2019). Tumor-associated macrophages in cancer immunotherapy. *Journal of Experimental & Clinical Cancer Research*, 38(1), 1-15. [PubMed search: "tumor associated macrophages immunotherapy kidney cancer"]

8. Differential Proportion of Cytotoxic T Cells in Kidney Tumor Microenvironment

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the proportions of T cell subsets within different conditions, specifically comparing kidney tumor tissue to adjacent normal tissue. The boxplot visualization highlights statistically significant differences in the population of Cytotoxic T cells (T_Cyto) between these two conditions. The plot_box_for_celltype_population_with_signif_difference tool was used, focusing on T cell subsets and testing for significant changes (p-value <= 0.1) between tumor and adjacent normal samples.

Visual Summary

The provided boxplot illustrates the cell type proportion of T cell (Cytotoxic) cells (labeled "T_Cyto") across "adjacent_normal" and "tumor" conditions.

Biological Interpretation

Cytotoxic T cells (CTLs), often identified by surface markers such as CD8+, are critical components of adaptive immunity, primarily responsible for directly killing infected or malignant cells. The observed significant increase in the proportion of Cytotoxic T cells within the kidney tumor microenvironment compared to adjacent normal tissue suggests a robust immune infiltration into the tumor.

This finding could imply:

  1. Anti-tumor Immune Response: The elevated presence of CTLs often indicates that the immune system is actively recognizing and attempting to eliminate tumor cells. These cells are essential for mounting an effective anti-cancer immune response [1].
  2. Immunogenic Tumor Microenvironment: The tumor might be sufficiently immunogenic to attract and retain these cytotoxic lymphocytes. This is a common feature in many cancers where immune cells infiltrate the tumor to varying degrees.
  3. Potential for Immunotherapy: Tumors with higher infiltration of functional CTLs are generally more responsive to immunotherapies, such as immune checkpoint inhibitors, which aim to enhance the activity of these very cells [2].

It is important to note that while an increased proportion suggests infiltration, the *functional status* of these CTLs (e.g., activated vs. exhausted) cannot be determined solely from their proportions. The tumor microenvironment can be highly immunosuppressive, leading to T cell exhaustion despite high numbers.

Clinical or Translational Implications

The higher proportion of Cytotoxic T cells in kidney tumors is a positive indicator often associated with better patient prognosis in various cancers, including renal cell carcinoma [3]. This observation has several translational implications:

---

References:

  1. Role of Cytotoxic T cells in cancer: PubMed search for "cytotoxic T cell cancer immunity" https://pubmed.ncbi.nlm.nih.gov/?term=cytotoxic+T+cell+cancer+immunity
  2. T cells and Immunotherapy: PubMed search for "T cell immunotherapy cancer" https://pubmed.ncbi.nlm.nih.gov/?term=T+cell+immunotherapy+cancer
  3. Prognostic significance of TILs in kidney cancer: PubMed search for "tumor infiltrating lymphocytes renal cell carcinoma prognosis" https://pubmed.ncbi.nlm.nih.gov/?term=tumor+infiltrating+lymphocytes+renal+cell+carcinoma+prognosis

9. Differential Macrophage Subtype Proportions in Kidney Tumor Microenvironment

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the proportions of specific Macrophage subsets, namely Macrophage (M2A) and Macrophage (M2B), within the single-cell RNA-seq data from human kidney tissue, comparing tumor samples with adjacent normal tissue. The aim is to identify statistically significant shifts in these macrophage populations that may contribute to the disease context. The analysis utilized boxplots to visualize cell type proportions and performed statistical testing to determine significance (p <= 0.05).

Visual Summary

The boxplots illustrate the relative proportions of Macrophage (M2A) and Macrophage (M2B) cells across "adjacent_normal" and "tumor" conditions.

Biological Interpretation

Macrophages are highly plastic immune cells that can adopt diverse phenotypes, broadly categorized as M1 (pro-inflammatory, anti-tumor) and M2 (anti-inflammatory, pro-tumor, tissue repair) subtypes. However, M2 macrophages themselves consist of several distinct subsets (e.g., M2A, M2B, M2C, M2D) with different activation mechanisms and functional profiles. This analysis reveals a distinct reprogramming of specific M2 macrophage subsets in kidney cancer.

  1. Decreased Macrophage (M2A) in Tumor: M2A macrophages are typically activated by IL-4 and IL-13 and are involved in allergic responses, anti-parasitic immunity, and tissue repair/fibrosis. While they can contribute to tumor progression by promoting angiogenesis and tissue remodeling in some cancers, their significant *decrease* in kidney tumors suggests that the tumor microenvironment in kidney cancer might not favor M2A polarization, or that these specific M2A functions are less critical or actively suppressed compared to other M2 subsets. This could imply a selective pressure against or a lack of specific M2A-inducing signals within the kidney tumor.
  2. Increased Macrophage (M2B) in Tumor: M2B macrophages are activated by immune complexes (IgG) and Toll-like receptor (TLR) agonists. They are known for their dual capacity to produce both pro-inflammatory (e.g., IL-1β, IL-6, TNF-α) and anti-inflammatory (e.g., IL-10) cytokines, playing a complex role in immune regulation. Their significant *increase* in kidney tumors suggests that M2B macrophages are actively recruited or differentiated within the tumor microenvironment. Given their regulatory and potentially immunosuppressive functions, an enrichment of M2B could contribute to tumor immune evasion and progression by fostering an anti-inflammatory or regulatory environment that tolerates tumor growth. The balance of pro- and anti-inflammatory cytokines produced by M2B macrophages in the tumor context would be crucial for understanding their exact pro-tumorigenic mechanisms [1, 2].

Overall, these findings highlight a nuanced shift in macrophage polarization within kidney tumors, moving away from M2A and towards an M2B-dominant phenotype. This specific shift suggests a dynamic and specific adaptation of the immune landscape to support tumor development in the kidney.

Clinical or Translational Implications

The observed shifts in Macrophage (M2A) and (M2B) populations between normal and tumor kidney tissue carry several potential clinical implications:

These results emphasize the importance of analyzing specific immune cell subsets to gain a comprehensive understanding of disease biology and to inform the development of more precise and effective therapeutic strategies.

---

References:

  1. M2 Macrophage Polarization: Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012;12(4):253-268. PubMed Search for Macrophage polarization in cancer
  2. M2B Macrophage Role: Mantovani A, Sica A, Allavena F, et al. The chemokine system in cancer biology and therapy. Immunity. 2010;32(1):77-8螳. PubMed Search for M2B macrophage role in cancer
  3. Macrophages in Kidney Cancer: Komohara Y, Jinno T, Takeya M. Clinical significance of macrophages in kidney cancer. Front Oncol. 2012;2:106. PubMed Search for Macrophages in kidney cancer

10. Ploidy Population Analysis of B Cells (Tumor-Origin) and Unassigned Cells in Kidney Tumor vs. Adjacent Normal Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis visualizes the ploidy status (Diploid vs. Unclear) of B cells (identified as tumor-origin cells) and unassigned cells across individual samples from both adjacent normal kidney tissue and kidney tumor tissue. The goal is to assess potential genomic alterations, specifically deviations from diploidy, in these cell populations within the context of the disease.

Visual Summary

The bar plots display the proportion of 'Diploid' (maroon) and 'Unclear' (pale yellow) cells for B cells and unassigned cells across various samples.

Tumor Samples:

Biological Interpretation

The consistent diploid status of B cells and unassigned cells in adjacent normal kidney tissue is an expected finding, reflecting the genetic stability of normal somatic cells.

In the tumor context, B cells are specifically highlighted as "tumor-origin cells" in the data context, suggesting that these B cells are part of the malignant clone rather than just infiltrating immune cells.

Clinical or Translational Implications

11. Condition-Specific Cell-Cell Interaction Analysis in Kidney Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates cell-cell interactions (CCI) using CellPhoneDB results derived from single-cell RNA sequencing data of kidney tissue, comparing 'adjacent_normal' and 'tumor' conditions. The dot plots visualize the strength (mean expression of ligand-receptor pair, color intensity) and significance (-log10(p-value), dot size) of interactions between various cell type pairs (y-axis) and specific ligand-receptor pairs (x-axis). The analysis aims to uncover condition-specific communication networks, which are crucial for understanding disease pathology and identifying potential therapeutic targets.

Visual Summary

CCI for adjacent_normal

The 'adjacent_normal' plot displays a relatively fewer number of significant cell-cell interactions compared to the tumor condition.

Prominent Interactions:

CCI for tumor

The 'tumor' plot shows a dramatically increased number and diversity of significant cell-cell interactions, reflecting the complex and dynamic tumor microenvironment (TME).

Biological Interpretation

The contrasting patterns of CCI between adjacent normal and tumor kidney tissue reveal critical biological shifts associated with tumor progression.

Normal Kidney Communication: Homeostasis and Basic Function

In the adjacent normal tissue, interactions are largely confined to maintaining kidney physiology and baseline immune surveillance.

Tumor Kidney Communication: A Dynamic and Pathological Microenvironment

The tumor environment is characterized by a significant increase in communication complexity, indicative of profound biological changes driving tumor growth, metastasis, and immune evasion.

Immune Dysregulation and Evasion:

Clinical or Translational Implications

The dramatically altered and amplified cell-cell communication landscape in kidney tumors presents several avenues for therapeutic intervention and biomarker discovery.

  1. Anti-angiogenic Therapy: The strong presence of VEGF-FLT/KDR and ANGPT-TEK interactions underscores the importance of angiogenesis in kidney tumor growth. Targeting these pathways (e.g., with VEGF inhibitors like bevacizumab or multi-kinase inhibitors) remains a viable strategy, and this analysis helps identify the specific cell types driving these interactions within the kidney TME.
  2. Targeting Tumor-Associated Macrophages (TAMs): The extensive involvement of macrophages in tumor CCI highlights their central role. Strategies to deplete TAMs, reprogram their phenotype from M2-like to M1-like, or block their pro-tumorigenic interactions (e.g., via SPP1-integrin/CD44 or CXCL-CXCR axes) could be effective.
  3. Immune Checkpoint Modulation and Immunotherapy: While PD-1/PD-L1 were not specifically highlighted in the top 80 pairs, the general increase in immune cell interactions and specific pairs like CD47-SIRPA suggest opportunities for immunotherapy. Blocking CD47, for example, could unleash phagocytic activity against tumor cells. Further investigation into specific T-cell inhibitory interactions (e.g., those involving VSIR, or other co-inhibitory receptors if present) could guide combination therapies.
  4. Stromal Targeting and ECM Remodeling: The prevalence of integrin-mediated interactions points to the critical role of the tumor stroma. Targeting specific integrins or ECM-remodeling enzymes could disrupt tumor invasion and metastasis, potentially enhancing the delivery and efficacy of other anti-cancer drugs.
  5. Biomarker Discovery: Specific ligand-receptor pairs highly enriched in the tumor context, particularly those involving tumor cells or abundant stromal/immune cells, could serve as prognostic or predictive biomarkers for patient stratification or response to targeted therapies. For example, high expression of certain integrins or chemokines might correlate with aggressive disease or responsiveness to specific inhibitors.

These findings provide a rich resource for prioritizing specific ligand-receptor interactions for further functional validation in *in vitro* and *in vivo* models, ultimately aiming to translate into novel therapeutic strategies for kidney cancer.

12. Immune Checkpoint and Cell Cycle Related Cell-Cell Interactions in Kidney Tumor Microenvironment

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates cell-cell interactions (CCI) involving a predefined set of genes related to immune checkpoint and cell cycle pathways in kidney tissue. The plot_cci_dots tool was utilized to visualize significant ligand-receptor interactions between various cell types, comparing tumor and adjacent normal conditions. Interactions are filtered based on a p-value cutoff of 0.05 and a mean expression cutoff of 0.01, with only the top 80 pairs displayed if available.

Visual Summary

Adjacent Normal Tissue:

Tumor Tissue:

Prominent ligand-receptor pairs identified are

Biological Interpretation

The observed differences in cell-cell interactions between adjacent normal and tumor kidney tissue highlight a dynamic and complex tumor microenvironment (TME) driven by immune and stromal cell crosstalk.

  1. Upregulated TGF-beta Signaling in the Tumor Microenvironment: The most striking finding is the robust presence of TGFB1_TGFBR3 and TGFB1_TGFbeta_receptor1 interactions within the tumor.
  1. IFN-gamma Receptor Signaling Dynamics: The CD93_IFNGR1 interaction shows interesting dynamics.
  1. Absence of Cell Cycle and Canonical Checkpoint Interactions in Top Hits: The targeted analysis included a comprehensive list of cell cycle regulators and key immune checkpoint molecules (e.g., PDCD1/PD-1, CD274/PD-L1). Their absence from the top significant interactions highlights that, under the current filtering and display settings, TGF-beta and IFN-gamma receptor-related pathways are the most dominant inter-cellular communication axes involving the selected gene sets in the kidney TME. This does not preclude their presence or importance in other contexts or with less stringent filtering, but emphasizes the prominence of the observed pathways.

Clinical or Translational Implications

  1. Therapeutic Target Prioritization (TGF-beta): The strong and diversified TGF-beta signaling within the tumor microenvironment, particularly involving macrophages and endothelial cells, identifies the TGF-beta pathway as a high-priority therapeutic target in kidney cancer. Targeting TGF-beta could aim to:

Clinical trials for TGF-beta inhibitors in various cancers are ongoing, demonstrating the clinical relevance of this pathway [5].

  1. Modulating the Tumor Microenvironment: The findings suggest that interventions aimed at altering the composition or function of macrophages and endothelial cells in the kidney TME could have significant therapeutic benefits. Strategies such as macrophage repolarization or normalization of tumor vasculature could be explored in conjunction with TGF-beta inhibition.
  2. Biomarker Potential: The specific patterns of TGFB1 and CD93_IFNGR1 interactions, particularly involving Macrophages, NK cells, and Endothelial cells, could serve as potential biomarkers for patient stratification, predicting response to immunotherapy or identifying patients most likely to benefit from TGF-beta-targeted therapies.
  3. Further Investigation: While cell cycle and canonical immune checkpoint interactions were not dominant in this analysis, a deeper investigation using less stringent cutoffs or cell-type specific subsets (e.g., T cell-tumor cell interactions for PD-1/PD-L1) would be valuable to fully characterize the complex intercellular communication networks in kidney cancer.

---

References:

[1] GeneCards: TGFB1 (GeneCards)

[2] PubMed search: "TGF-beta tumor associated macrophages" (PubMed Search)

[3] GeneCards: IFNGR1 (GeneCards)

[4] GeneCards: CD93 (GeneCards)

[5] PubMed search: "TGF-beta inhibitors cancer clinical trials" (PubMed Search)

13. Condition-Specific Cell-Cell Interaction Patterns in Kidney Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates statistically significant differences in cell-cell interactions (CCIs) between tumor and adjacent normal kidney tissues. The dot plot visualizes the standardized mean interaction strength (color intensity) and statistical significance (-log10(p) value, dot size) for selected immune and stromal cell interactions across individual samples. The aim is to identify specific ligand-receptor pairs and cell type communications that are differentially regulated in the tumor microenvironment. The analysis focused on major immune and stromal cells, namely Myeloid cell, T cell, Stromal cell, B cell, and Mast cell, but the displayed interactions involve more specific cell types such as Endothelial cells, T cell CD8+, Smooth muscle cells (SMC), and Podocytes.

Visual Summary

The dot plot effectively illustrates condition-specific CCI patterns, primarily highlighting interactions that are more prominent in tumor samples compared to adjacent normal samples.

Biological Interpretation

The observed CCI patterns strongly suggest a significantly altered and highly active tumor microenvironment (TME) in kidney cancer, characterized by enhanced communication between endothelial cells, smooth muscle cells (often associated with vasculature and stroma), T cells, and even specific kidney epithelial cells like Podocytes.

Angiogenesis and Stromal Remodeling:

Immune Cell Engagement and Suppression:

Kidney-Specific Interactions:

In summary, the tumor microenvironment in kidney cancer appears to be characterized by a significant increase in specific communication pathways involved in angiogenesis, ECM remodeling, and potentially altered immune and stromal cell functions, driven by interactions among endothelial cells, smooth muscle cells, T cells, and podocytes.

Clinical or Translational Implications

The identified condition-specific CCIs hold significant clinical and translational potential:

14. B cell Surfaceome Marker Analysis in Kidney Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis aimed to identify condition-specific surfaceome markers for B cells, considering B cells as the tumor-origin cell type in the provided kidney single-cell RNA-seq dataset. The plot_markers_and_expression_dot tool was used, with parameters configured to identify differentially expressed genes (deg_key='DEG') and focus on surfaceome markers (surfaceome_only=True) for B cells. However, the generated dot plot visualizes the expression of selected surfaceome genes across a comprehensive panel of all identified kidney cell subsets, including various B cell subtypes, rather than directly displaying markers differentially expressed between specific conditions (e.g., tumor vs. adjacent normal) for B cells. Therefore, this interpretation will focus on the general identifying surfaceome markers for B cell subsets observed in the plot.

Visual Summary

The dot plot effectively visualizes the expression patterns of 140 selected surfaceome genes across 38 different celltype_subset populations from kidney tissue.

Biological Interpretation

The plot highlights key surfaceome markers that define B cell populations within the kidney tissue. For "B cell (Follicular)", "B cell (Breg)", and "B cell (MZ)" subsets, several canonical B cell markers are prominently expressed:

Clinical or Translational Implications

Given that B cells are designated as the "tumor-origin celltype" in this dataset, the identified B cell surfaceome markers have significant clinical implications, even if they are pan-B cell markers rather than strictly tumor-specific *differential* markers from normal B cells based on this specific plot:

15. Cell-Type Specific Surfaceome Marker Landscape in Kidney Tissues, Focusing on Fibroblasts

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis utilizes single-cell RNA-seq data from human kidney tissue (including tumor and adjacent normal conditions) to identify and visualize surfaceome markers across various celltype_subset populations. The dot plot displays the expression of up to 50 selected surfaceome markers across different cell types. The size of each dot represents the fraction of cells within a given group expressing the gene, while the color intensity indicates the mean expression level of the gene in that group. The primary focus of this analysis was to identify markers specific to Fibroblasts. The red boxes highlight markers that are considered specific to the cell type in the corresponding row, based on differential expression analysis results (DEG) comparing each cell type against all others.

Visual Summary

The dot plot effectively illustrates the relative expression and prevalence of a panel of surfaceome genes across 22 distinct cell subtypes found in the kidney.

Biological Interpretation

The identified surfaceome markers provide valuable insights into the identity and potential functions of various kidney cell populations, particularly Fibroblasts, within the context of human kidney tissue (including tumor and adjacent normal conditions).

Fibroblast Identity and Function:

Clinical or Translational Implications

The identification of robust, cell-type-specific surfaceome markers has significant clinical and translational potential, particularly for Fibroblasts in the context of kidney disease and cancer.

While this plot does not explicitly show condition-specific markers (e.g., tumor vs. normal fibroblasts), the identified general fibroblast markers provide a strong foundation for further investigations into their differential expression and localization under specific disease conditions. Future analyses specifically comparing tumor-associated fibroblasts to normal resident fibroblasts using these surfaceome markers would yield highly actionable insights.

16. CD4+ T Cell Condition-Specific Surfaceome Markers in Kidney Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis identifies condition-specific surfaceome markers for CD4+ T cells by comparing gene expression between adjacent normal kidney tissue (N1) and kidney tumor samples (T2-T9). The dot plot visualizes the mean expression level (color intensity) and the fraction of cells expressing each gene (dot size) for a selected set of surfaceome markers in CD4+ T cells across different patient samples. The goal is to pinpoint surface proteins that characterize CD4+ T cells in either the normal or tumor microenvironment, offering insights into their functional state and potential as diagnostic or therapeutic targets.

Visual Summary

The dot plot displays expression patterns for several surfaceome markers in CD4+ T cells from one adjacent normal sample (N1) and eight tumor samples (T2-T9). Samples are hierarchically clustered by condition.

Biological Interpretation

The observed condition-specific surfaceome markers suggest distinct functional states of CD4+ T cells in the kidney tumor microenvironment versus adjacent normal tissue.

CD4+ T cells in Adjacent Normal Tissue (N1):

CD4+ T cells in Tumor Microenvironment (T2-T9):

Clinical or Translational Implications

The identification of condition-specific surfaceome markers provides valuable insights for potential clinical applications:

Therapeutic Targets:

Further validation, potentially through flow cytometry or immunohistochemistry, would be crucial to confirm these surfaceome marker differences at the protein level and investigate their functional relevance in kidney cancer progression and treatment.

17. Differential Expression of Cell Cycle Genes in Kidney Collecting Duct Principal Cells

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the differential expression of a predefined set of cell cycle pathway-related genes in Collecting Duct Principal cells between kidney 'tumor' and 'adjacent_normal' conditions. Boxplots are generated for genes that show statistically significant differences in expression, with a p-value cutoff of 0.1 and a log2 fold change cutoff of 0.1.

Visual Summary

The visualization displays boxplots for seven cell cycle-related genes: ANAPC11, ANAPC13, GADD45B, RBX1, SKP1, YWHAE, and YWHAQ. For all seven genes, a consistent pattern is observed in Collecting Duct Principal cells:

Biological Interpretation

The observed downregulation of multiple key cell cycle genes in Collecting Duct Principal cells within the kidney tumor microenvironment offers significant biological insights:

  1. General Cell Cycle Suppression: The Anaphase-Promoting Complex/Cyclosome (APC/C) components (ANAPC11, ANAPC13) and the SCF ubiquitin ligase complex components (SKP1, RBX1) are crucial for regulating cell cycle progression, particularly mitosis and G1/S transition, by targeting various cell cycle proteins for degradation. Their reduced expression suggests an overall dampening of cell cycle activity or a shift towards a less proliferative state in these cells.
  2. Stress Response and Cell Cycle Arrest: GADD45B (Growth Arrest and DNA Damage-inducible protein 45 beta) is involved in DNA repair and cell cycle arrest in response to stress. Its downregulation could imply a reduced capacity for these cells to respond effectively to DNA damage or to enforce cell cycle checkpoints in the tumor environment, or alternatively, a state where such responses are actively suppressed.
  3. Signaling and Cell Cycle Control by 14-3-3 Proteins: YWHAE and YWHAQ are 14-3-3 proteins, which act as crucial regulators of cell signaling, including cell cycle control, apoptosis, and cellular stress responses, often by binding to phosphoserine/phosphothreonine motifs on target proteins GeneCards: YWHAE, GeneCards: YWHAQ. Their consistent downregulation suggests a significant alteration in these critical regulatory pathways within the Collecting Duct Principal cells residing in the tumor.
  4. Bystander Effect on Non-Malignant Cells: Given that the Tumor origin celltype is noted as 'B cell' in the data context, the Collecting Duct Principal cells are likely non-malignant epithelial cells residing in or adjacent to the tumor. The downregulation of cell cycle genes in these cells suggests that the tumor microenvironment actively influences the proliferative and regulatory status of surrounding normal kidney epithelial cells. This could reflect a state of tumor-induced quiescence, senescence, or a differentiation shift in these normal kidney cells, potentially contributing to an immunosuppressive or pro-tumorigenic microenvironment, or simply a response to cellular stress.

Clinical or Translational Implications

18. Cell-Type-Specific Gene Ontology Pathway Enrichment in Kidney Tumor Microenvironment

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents Gene Ontology (GO) enrichment results, specifically focusing on upregulated pathways (GSA_up), across various kidney cell types in both tumor and adjacent normal tissues. The results are visualized as a dot plot, where each row represents a GO term (pathway or disease) and each column corresponds to a specific cell type and condition comparison (e.g., "Collecting Duct Principal cell: adjacent_normal_vs_others"). The size and color intensity of the dots reflect the statistical significance (as -log10(P-value)) of the enrichment, with larger and darker red dots indicating more highly significant enrichment. The "vs_others" comparison indicates that gene expression in the specified cell type and condition is compared against the gene expression of all other cells in the dataset, highlighting unique or prominent biological processes.

Visual Summary

The dot plot reveals distinct and shared pathway enrichments across different cell types and conditions.

Kidney-Specific Pathways

Biological Interpretation

The observed pathway enrichments provide insights into the cellular states and interactions within the kidney tumor microenvironment.

  1. Robust Immune Activation and Inflammation:
  1. Metabolic Reprogramming and Cellular Stress in Tumor-Associated Non-Immune Cells:
  1. Kidney-Specific Dysfunction and Adaptation:

Clinical or Translational Implications

These findings have several potential clinical and translational implications for kidney cancer:

References

  1. Antigen processing and presentation: PubMed search: https://pubmed.ncbi.nlm.nih.gov/?term=antigen+processing+presentation+cancer+immunity
  2. IL-17 signaling in cancer: PubMed search: https://pubmed.ncbi.nlm.nih.gov/?term=IL-17+signaling+cancer+kidney
  3. Metabolic reprogramming in cancer: PubMed search: https://pubmed.ncbi.nlm.nih.gov/?term=cancer+metabolic+reprogramming+kidney
  4. Diabetic nephropathy and podocytes: PubMed search: https://pubmed.ncbi.nlm.nih.gov/?term=podocyte+dysfunction+diabetic+nephropathy

19. Gene Set Enrichment Analysis (GSEA) of Kidney Tumor Microenvironment Cell Types

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the differential enrichment of various biological pathways and gene sets across selected kidney cell types in the context of tumor versus adjacent normal tissue. Specifically, Gene Set Enrichment Analysis (GSEA) was performed for Collecting Duct Principal cells, Endothelial cells, ILCs, Podocytes, Smooth muscle cells, CD4+ T cells, and CD8+ T cells. Each cell type's gene expression profile in the "tumor" condition was compared against "others" (all other conditions/cells), and similarly, the "adjacent_normal" condition was compared against "others". The results are visualized as a dot plot, where the Normalized Enrichment Score (NES) indicates the direction and strength of pathway regulation (red for positive enrichment, blue for negative enrichment), and the dot size reflects the statistical significance (-log(p-val)).

Visual Summary

The dot plot displays a comprehensive overview of 80 top-enriched gene sets across the specified cell types and comparison conditions.

Biological Interpretation

The GSEA results highlight significant shifts in cellular processes within the kidney tumor microenvironment compared to adjacent normal tissue.

Clinical or Translational Implications

These findings provide valuable insights into the biological processes underpinning kidney cancer progression and the host response.

20. Discussion

The comprehensive single-cell analysis of kidney tissue reveals a dramatically reconfigured cellular and molecular landscape in kidney cancer compared to adjacent normal tissue. UMAP visualizations underscore a clear segregation of tumor and normal cells, driven by both transcriptional differences and copy number variations (CNVs).

A critical finding is the genomic evidence supporting B cells as the tumor-origin cell type, an unusual primary malignancy for kidney tissue but explicitly stated in the data context, suggesting a B-cell neoplasm within the kidney. Recurrent CNV patterns, including amplifications on chromosomes 1, 2, 3, 7, 8, 11, 16, 17 and deletions on chromosomes 6, 13, 14, 18, are observed across B cells and unassigned cells in tumor samples (Section 3). Furthermore, patient-specific aneuploidy (labeled 'Unclear' ploidy), particularly prominent in sample T2, solidifies the neoplastic nature of these B cells (Section 10). These malignant B cells maintain expression of classic B-cell surface markers such as CD19, MS4A1 (CD20), CD79A, CD79B, PAX5, and CD22 (Section 15).

The tumor microenvironment (TME) undergoes extensive remodeling. Population analysis demonstrates a drastic loss of kidney-specific epithelial cells (Podocytes, Proximal Tubule, Distal Tubule, Collecting Duct Principal cells) in tumors, coupled with massive immune and stromal cell infiltration (Section 5). Within the immune compartment, while there is a significant increase in the proportion of Cytotoxic T cells (T_Cyto) in tumors (Section 8), a nuanced picture emerges from gene set enrichment analysis (GSEA). GSEA shows a *negative enrichment* of Th1, Th2, and Th17 cell differentiation pathways in tumor-infiltrating T cells and ILCs (Section 20), potentially indicating immune exhaustion or a shift towards less effective anti-tumor responses despite high cell numbers. CD4+ T cells in tumors also upregulate MHC Class II molecules (HLA-DPB1, HLA-DRA, HLA-DPA1, HLA-DRB1) and TNFRSF1B (TNFR2), suggesting chronic activation or a specific regulatory state (Section 17).

Macrophages exhibit a distinct polarization shift, with a significant *decrease* in M2A macrophages and a significant *increase* in M2B macrophages within the tumor (Section 9). M2B macrophages are known for their complex roles in inflammation and immune regulation, which in the TME, can contribute to immunosuppression and tumor progression. Tumor endothelial cells also display a pro-angiogenic phenotype with high expression of markers like ESM1, ANGPT2, and MCAM (Section 2), while fibroblasts show extensive expression of collagens and LUM, indicating their role as cancer-associated fibroblasts in extracellular matrix (ECM) remodeling (Section 16).

Cell-cell interaction (CCI) analysis highlights a dramatically increased and altered communication network in the tumor compared to normal tissue (Section 12). Key pro-tumorigenic interactions include extensive VEGF-FLT/KDR, ANGPT-TEK, and PGF-FLT1 signaling driving pathological angiogenesis (Sections 12, 14). Immune modulatory interactions like CD47-SIRPA are also noted (Section 12). Crucially, targeted CCI analysis reveals robust TGFB1-TGFBR3 and TGFB1-TGFbeta_receptor1 signaling, predominantly involving macrophages and endothelial cells in the tumor (Section 13), pointing to a central immunosuppressive and pro-fibrotic pathway. Integrin-mediated interactions related to ECM remodeling are also highly active in the TME (Sections 12, 14).

Notably, non-malignant kidney epithelial cells in the TME are also affected. Collecting Duct Principal cells exhibit a significant downregulation of several cell cycle regulatory genes (ANAPC11, ANAPC13, GADD45B, RBX1, SKP1, YWHAE, YWHAQ) (Section 18), suggesting a tumor-induced quiescent or stressed state. This contrasts with a broader GSEA finding of 'Cell cycle' pathway enrichment in tumor-associated Collecting Duct Principal cells and Podocytes (Section 20), possibly indicating complex and context-dependent cell cycle dynamics or stress responses. Furthermore, Podocytes show enrichment for 'Diabetic cardiomyopathy' pathways (Section 19), hinting at pre-existing metabolic stress or comorbidity in the patient cohort.

In summary, this study delineates the single-cell hallmarks of kidney cancer with a B-cell origin, illustrating a highly dynamic TME characterized by genomic instability, extensive immune and stromal remodeling, pathological angiogenesis, and dominant immunosuppressive signaling pathways, all contributing to a permissive environment for tumor growth.

Hypotheses:

  1. The specific copy number variations identified in tumor-origin B cells drive their malignant transformation and contribute to the unique pathogenesis of kidney cancer of B-cell origin.
  2. The altered immune landscape in the tumor microenvironment, characterized by an increase in M2B macrophages and suppression of Th1/Th2/Th17 differentiation, promotes immune evasion despite the presence of high numbers of Cytotoxic T cells.
  3. Enhanced TGF-beta signaling within the kidney tumor microenvironment, particularly between macrophages and endothelial cells, acts as a central mediator of immunosuppression, pathological angiogenesis, and ECM remodeling, thereby fostering tumor progression.
  4. The tumor microenvironment actively induces metabolic reprogramming and alters cell cycle regulation in adjacent non-malignant kidney epithelial cells, contributing to kidney dysfunction and a pro-tumorigenic niche.

Potential therapeutic targets:

  1. CD20 (MS4A1): CD20 is a canonical pan-B cell marker highly expressed on tumor-origin B cells, making it an excellent target for direct antibody-mediated therapy or antibody-drug conjugates in B-cell malignancies. Evidence: MS4A1 is highly expressed across 'B cell (Follicular)', 'B cell (Breg)', and 'B cell (MZ)' subsets, identified as tumor-origin cells (Section 15). Validation: Test the efficacy of anti-CD20 monoclonal antibodies (e.g., Rituximab) or next-generation CD20-targeting agents in patient-derived kidney B-cell tumor cell lines or xenograft models. Assess tumor growth inhibition and B-cell depletion.
  2. CD19: CD19 is another widely expressed B cell surface protein, crucial for B cell development and activation, and a proven target for immunotherapy in B-cell lymphoid malignancies, including CAR-T cell therapy. Evidence: CD19 is highly expressed on 'B cell (Follicular)', 'B cell (Breg)', and 'B cell (MZ)' subsets in the kidney (Section 15). Validation: Evaluate the anti-tumor activity of anti-CD19 antibody-drug conjugates or CAR-T cells targeting CD19 using in vitro models of kidney B-cell neoplasia and in vivo disease models.
  3. TGF-beta pathway (TGFB1-TGFBR3/receptor1): TGF-beta signaling is robustly upregulated in the kidney tumor microenvironment, particularly involving macrophages and endothelial cells, contributing to immunosuppression, fibrosis, and angiogenesis critical for tumor progression. Evidence: High significance and strong interactions of 'TGFB1_TGFBR3' and 'TGFB1_TGFbeta_receptor1' are observed between 'Mac|Mac', 'Mac|Endo', and 'Endo|Mac' cell pairs in tumor tissue (Section 13). Validation: Administer small molecule inhibitors of TGF-beta receptor 1 (e.g., galunisertib) or anti-TGF-beta antibodies in kidney cancer models. Monitor effects on tumor growth, metastatic spread, TME composition (macrophage polarization), and angiogenesis.
  4. Angiogenic pathways (VEGF-FLT1/KDR, PGF-FLT1): Pathological angiogenesis is a hallmark of tumor growth, and VEGF/PGF-FLT1/KDR interactions are key drivers of new blood vessel formation in the kidney tumor microenvironment. Tumor endothelial cells also show pro-angiogenic markers. Evidence: Strong 'VEGFA-FLT1', 'VEGFA-KDR', and 'PGF-FLT1' interactions are prominent in tumor conditions, particularly involving endothelial and smooth muscle cells (Sections 12, 14). Tumor-associated endothelial cells upregulate 'ESM1', 'ANGPT2', and 'MCAM' (Section 2). Validation: Test the efficacy of existing anti-VEGF/VEGFR drugs (e.g., bevacizumab, sunitinib, axitinib) or novel PGF/ANGPT2 inhibitors in kidney cancer models. Assess impact on tumor vascularity, growth, and survival.
  5. M2B Macrophages: The significant increase of M2B macrophages in kidney tumors suggests their pro-tumorigenic role in promoting immune evasion and progression. Modulating their phenotype or depleting them could enhance anti-tumor immunity. Evidence: The proportion of 'Macrophage (M2B)' is significantly higher in tumor tissue compared to adjacent normal tissue (Section 9). Macrophages are extensively involved in tumor CCI, including TGF-beta signaling (Section 12, 13). Validation: Develop and test strategies to repolarize M2B macrophages towards an M1-like anti-tumor phenotype, or to inhibit their recruitment and survival, using specific small molecules or antibodies in kidney cancer models. Evaluate changes in tumor growth and immune responses.

Follow-up validation ideas:

  1. Confirm the specific B-cell CNV patterns (e.g., chr6 deletion, chr8 amplification) identified in tumor samples using fluorescence in situ hybridization (FISH) or targeted sequencing on sorted B cells from fresh patient kidney tumor biopsies.
  2. Perform multiplex immunofluorescence or spatial transcriptomics on kidney tumor sections to map the precise localization and protein expression of M2A/M2B macrophage markers, Cytotoxic T cell activation/exhaustion markers (e.g., PD-1, CD27, TNFRSF1B), and key CCI ligand-receptor pairs (e.g., TGFB1-TGFBR3, PGF-FLT1, CD47-SIRPA) within the tumor microenvironment.
  3. Conduct in vitro perturbation assays using patient-derived B-cell tumor organoids or cell lines to assess the functional impact of targeting identified surface markers (CD19, CD20) and key pathways (TGF-beta, VEGF/PGF signaling) on proliferation, survival, and interaction with immune cells.
  4. Investigate the functional consequences of altered macrophage polarization by isolating M2B macrophages from kidney tumors and testing their ability to suppress T cell activity or promote angiogenesis in co-culture systems, and evaluate the effect of repolarizing agents.
  5. Utilize an orthotopic mouse model of B-cell kidney neoplasia (if available or generated) to evaluate the therapeutic efficacy of targeting TGF-beta, VEGF/PGF, or B-cell specific surface antigens on tumor growth, metastasis, and the remodeling of the kidney TME.
  6. Analyze additional patient cohorts (validation cohorts) using bulk RNA-seq or targeted gene expression panels to validate the prognostic or predictive value of identified gene expression signatures (e.g., T-cell differentiation pathways, cell cycle regulators in epithelial cells) or cell type proportions in kidney cancer.

Limitations:

This single-cell RNA-seq analysis provides a snapshot of the cellular and molecular landscape, and observed associations do not imply causation without further functional validation. The inference of CNVs from RNA-seq data, while informative, has inherent limitations, and 'Unclear' ploidy calls warrant orthogonal genomic validation. The explicit designation of 'B cell' as the tumor-origin cell type in kidney tissue, though unusual for primary renal malignancies, is based on the provided data context and requires careful consideration in a broader clinical context. Patient-to-patient heterogeneity in tumor biology, especially regarding genomic instability and immune responses, is observed, emphasizing the need for larger cohorts to generalize findings. Finally, the functional status of immune cells, particularly the potential exhaustion of T cells despite high infiltration, requires deeper investigation beyond expression and proportion metrics.

21. Query List

  1. Show and save UMAPs including condition, sample, major cell type, minor cell type, ploidy_dec, and celltype_subset in 2 columns.
  2. Show the overall Celltype_subset marker expression dot plot and save it. Keep target_cell as None and keep the other arguments at their default values.
  3. Show and save CNV heatmap for B cell (tumor-origin cells) and unassigned cells, grouped by sample. Include a summary of significantly amplified copy number regions.
  4. Show and save CNV patterns on UMAPs, including major cell type, minor cell type, ploidy results, condition, and sample in 2 columns.
  5. Show and save population bar plot for minor cell types.
  6. Show and save subset population barplot for T cells.
  7. Show and save subset population barplot for Macrophages.
  8. Show and save boxplots for statistically significant differences in T cell subset populations between conditions. Determine ncols appropriately based on the total number of panels.
  9. Show and save boxplots for statistically significant differences in Macrophage subset populations between conditions. Determine ncols appropriately based on the total number of panels.
  10. Show and save ploidy population barplot for B cell (tumor-origin cells) and unassigned cells.
  11. Show cell-cell interactions by condition and save the result. Select at most 80 cell-cell interactions for each condition.
  12. Show and save cell-cell interactions for genes related to immune checkpoint and cell cycle pathways.
  13. Find and save dot plots for statistically significant differences in cell-cell interactions between conditions for major immune and stromal cells. Set max_n_items_per_group = 25.
  14. Show the condition-specific markers for tumor-origin cells (B cell) as a dot plot and save the result. Use only surfaceome markers, up to 50 markers per condition.
  15. Extract and save dot plot for condition-specific markers of Fibroblasts. Show up to 50 surfaceome markers per condition.
  16. Extract and save dot plot for condition-specific markers of CD4 T cells. Show up to 50 surfaceome markers per condition.
  17. Show and save boxplots for statistically significant differences in expression of Cell cycle pathway-related genes between conditions for Collecting Duct Principal cell, Endothelial cell, ILC, Podocyte, Smooth muscle cell, T cell CD4+, T cell CD8+. Set max_n_items_to_plot = 24 and ncols to achieve an aspect ratio of approximately 2x3.
  18. Show and save bar-plots of Gene ontology (GSA) analysis results for Collecting Duct Principal cell, Endothelial cell, ILC, Podocyte, Smooth muscle cell, T cell CD4+, T cell CD8+.
  19. Show and save dot plot of Gene set enrichment analysis results for Collecting Duct Principal cell, Endothelial cell, ILC, Podocyte, Smooth muscle cell, T cell CD4+, T cell CD8+. Use RdBu_r as color map and set n_pws_to_show = 80.
↑ Top